Hardwig et al. [3] reported successful resolution of epiphora in 6 out of 10 external DCRs, with a follow-up ranging from 11 to 66 months, emphasizing the importance of GPA stabilization with immunosuppressive therapy before DCR. The gene discussed is GYPA; the disease is Epiphora.